1-Ethyl-6-aminouracil

CAS No. 41862-09-3

1-Ethyl-6-aminouracil( 6-AMINO-1-ETHYL-1H-PYRIMIDINE-2,4-DIONE )

Catalog No. M22255 CAS No. 41862-09-3

1-Ethyl-6-aminouracil is an intermediate in the synthesis of a series of new substituted Xanthines which have high affinity and selectivity for the human adenosine A2B receptors.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 45 In Stock
5MG 65 In Stock
10MG 91 In Stock
25MG 165 In Stock
50MG 248 In Stock
100MG 372 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    1-Ethyl-6-aminouracil
  • Note
    Research use only, not for human use.
  • Brief Description
    1-Ethyl-6-aminouracil is an intermediate in the synthesis of a series of new substituted Xanthines which have high affinity and selectivity for the human adenosine A2B receptors.
  • Description
    1-Ethyl-6-aminouracil is an intermediate in the synthesis of a series of new substituted Xanthines which have high affinity and selectivity for the human adenosine A2B receptors.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    6-AMINO-1-ETHYL-1H-PYRIMIDINE-2,4-DIONE
  • Pathway
    Apoptosis
  • Target
    Adenosine Receptor
  • Recptor
    A2B?adenosine receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    41862-09-3
  • Formula Weight
    155.16
  • Molecular Formula
    C6H9N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCn1c(N)cc(=O)nc1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • CI-947

    An orally active adenosine receptor agonist that can induce acute cardiovascular toxicity and coronary vascular injury in vivo.

  • LUF6000

    LUF6000 is a potent, selective, positive allosteric modulator (enhancer) of human A3 adenosine receptor.

  • Alloxazine

    Alloxazine (Isoalloxazine) is an A2 receptor antagonist, which is approximately 10-fold more selective for the A2B receptor than for the A2A receptor.